posted on 2014-03-04, 17:00authored byM.R. Towler, A.W. Wren, O.M. Clarkin, David A. Tanner
Glass polyalkenoate cements (GPCs) are acid base cements formed by the
reaction of an aqueous solution of polyalkenoic acid, usually polyacrylic acid (PAA)
with an acid degradable aluminosilicate glass. The result of the reaction is cement
consisting of reacted and unreacted glass particles embedded in a polysalt matrix. In
addition to these conventional GPCs, aluminium free glass polyalkenoate cements
based on zinc silicate glasses (Zn-GPCs) exhibit significant potential as bone cements
for several reasons. Primarily, they are formulated without the inclusion of aluminium
(Al) [1] in the glass phase and thus eliminate clinical complications arising from the
release of the Al3+ ion from the cement in vivo. Such complications have, in the past,
included aluminium induced encephalopathy [2-5] and defective mineralisation of
cancellous bone [6]. Secondly, Zn-GPCs set without a significant evolution of heat,
when compared with commercial bone cements such as Spineplex ® (Stryker,
Limerick, Ireland). Finally, these materials can be tailored to release clinically
beneficial ions into surrounding tissues [7]. In addition to Zn, these cements have
been synthesized to contain strontium (Sr) [8, 9]. Both Sr and Zn inhibit osteoclastic
turnover and promote osteoblastic turnover, resulting in increased bone strength and
decreased fracture risk [10-14].
History
Publication
Journal of Materials Science;43(3), pp. 1170-1173
Publisher
Springer
Note
peer-reviewed
Rights
The original publication is available at www.springerlink.com